Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer（OGSG0402）

T. Kishimoto , H. Imamura , N. Uedo , K. Fujitani , S. Iijima , H. Takiuchi , M. Imano , T. Shimokawa , Y. Kurokawa , H. Furukawa, Randomized phase II trial of S-1 plus irinotecan versus S-1 plus paclitaxel as first-line treatment for advanced gastric cancer (OGSG0402), ASCO 2009.